BioLife 解决方案 BLFS
$0.00 +$0.00 (0.00%)
休市 · Oct 22, 12:40 am ET
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值$1.89B
市盈率（TTM）32.7
股息率–
BLFS 相关新闻
匹配 BioLife Solutions 或代码 BLFS 的头条新闻，按最新排序。
- Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Hold Rating
- BioLife Solutions: BioLife Solutions, Inc. - Anticipated Adjustment Option Symbol: BLFS New Symbol: RGEN1
- Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, Vs. FactSet Est of $27.8M
- Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold Rating 负面
- Stephens Downgrades BioLife Solutions(BLFS.US) to Hold Rating, Raises Target Price to $31 中性
- Maxim Group Maintains BioLife Solutions(BLFS.US) With Hold Rating
- A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $31 to $31
- Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)
- H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $32
- TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
- Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $33
- Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32
- Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)
- Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $34
暂无评论——快来第一个聊聊 BLFS。
登录后参与讨论。